Trial Profile
A Phase I, Randomized, Dose-Ranging, Pharmacokinetic, Glucodynamic, Safety, and Tolerability Study of SC Administered Humulin R and Humalog With or Without Recombinant Human Hyaluronidase (rHuPH20) in Healthy Volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Insulin (Primary) ; Hyaluronidase; Insulin lispro
- Indications Diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Halozyme Therapeutics
- 14 Aug 2018 Status changed from active, no longer recruiting to completed.
- 30 May 2012 Planned end date changed from 1 Dec 2009 to 1 Jan 2013 as reported by ClinicalTrials.gov.
- 11 Dec 2009 Planned end date changed from 1 Oct 2009 to 1 Dec 2009 as reported by ClinicalTrials.gov.